Growing industry collaborations between CROs and biopharma companies is expected to offer new opportunities for preclinical research outsourcing. Additionally, market players are investing in R&D to develop novel preclinical models for cancer, neurological disorders, and rare diseases. https://www.newsanalyticspro.com/preclinical-assets-market-is-primed/